Now that laparoscopy during pregnancy is no longer considered too dangerous, should you remove a mass this way-and if so, when?
Laparotomy. In the past, pregnant patients who required surgical evaluation of a persistent adnexal mass underwent a laparotomy. Pregnancy was considered an absolute contraindication for laparoscopy due to the unknown effects of increased intra-abdominal pressure on a gravid uterus. That has changed within the last decade, however, as several studies comparing laparoscopy and laparotomy in pregnancy found no difference in fetal outcome between these two procedures.11,12 Furthermore, laparoscopy is commonly successful during pregnancy, with only a 3% conversion to laparotomy.13
Benefits of laparoscopy. Overall, laparoscopy is increasingly being chosen, given its many benefits over laparotomy, which are possibly even more substantial for pregnant patients. Intraoperatively, there's often less uterine manipulation when compared with laparotomy.14 Postoperatively, patients have shorter hospital stays, earlier mobilization, and a lower risk of thromboembolic events.15 Furthermore, avoidance of an abdominal scar in the face of a growing uterus can lead to less postoperative discomfort and a better cosmetic outcome.13,16
When is surgery indicated?
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More